Cargando…
Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort
BACKGROUND: Recurrent hepatitis C virus (HCV) infection after liver transplantation (LT) has been a frequent and relevant problem in the past two decades. This analysis evaluated the efficacy and safety of new interferon (IFN)-free direct-acting antiviral (DAA) therapies in a large real-world cohort...
Autores principales: | Bernuth, Sebastian, Grimm, Daniel, Vollmar, Johanna, Darstein, Felix, Mittler, Jens, Heise, Michael, Hoppe-Lotichius, Maria, Galle, Peter R, Lang, Hauke, Zimmermann, Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513830/ https://www.ncbi.nlm.nih.gov/pubmed/28744104 http://dx.doi.org/10.2147/DDDT.S139837 |
Ejemplares similares
-
Efficacy and safety of a conversion from the original tacrolimus and mycophenolate mofetil to the generics Tacpan(®) and Mowel(®) after liver transplantation
por: Vollmar, Johanna, et al.
Publicado: (2015) -
Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatment
por: Grimm, Daniel, et al.
Publicado: (2016) -
Elderly Patients with Hepatocellular Carcinoma Benefit from Liver Transplantation as Much as Younger Ones
por: Mittler, Jens, et al.
Publicado: (2022) -
Surgical therapy of primary hepatic angiosarcoma
por: Tripke, Verena, et al.
Publicado: (2019) -
Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: MELD, or not MELD, that is the question
por: Pitton, Michael B., et al.
Publicado: (2020)